DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 125 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2019. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33 | -99.9% | 2,260 | -81.2% | 0.00% | – |
| Q1 2020 | $43,000 | -40.3% | 12,000 | 0.0% | 0.00% | – |
| Q4 2019 | $72,000 | -92.5% | 12,000 | -95.6% | 0.00% | -100.0% |
| Q3 2019 | $963,000 | -53.1% | 272,000 | -48.9% | 0.01% | -40.0% |
| Q2 2019 | $2,054,000 | -62.3% | 532,000 | +32.3% | 0.01% | -68.8% |
| Q1 2019 | $5,447,000 | +46.6% | 402,000 | -6.2% | 0.03% | +28.0% |
| Q4 2018 | $3,716,000 | -31.8% | 428,600 | +6.6% | 0.02% | -21.9% |
| Q3 2018 | $5,447,000 | +5.3% | 402,000 | +18.9% | 0.03% | -5.9% |
| Q2 2018 | $5,171,000 | -10.5% | 338,000 | +15.0% | 0.03% | -15.0% |
| Q1 2018 | $5,777,000 | +1634.8% | 294,000 | +1370.0% | 0.04% | +1233.3% |
| Q4 2017 | $333,000 | 0.0% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $333,000 | +66.5% | 20,000 | 0.0% | 0.00% | +50.0% |
| Q2 2017 | $200,000 | +65.3% | 20,000 | 0.0% | 0.00% | +100.0% |
| Q1 2017 | $121,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital, LLC | 5,791,735 | $85,543,929 | 4.00% |
| Deep Track Capital, LP | 6,756,956 | $99,800,240 | 3.85% |
| Intrinsic Edge Capital Management LLC | 1,133,099 | $16,735,872 | 1.89% |
| Bain Capital Life Sciences Investors, LLC | 915,000 | $13,514,550 | 1.51% |
| Kynam Capital Management, LP | 500,000 | $7,385,000 | 1.21% |
| Rhenman & Partners Asset Management AB | 700,000 | $10,339,000 | 1.12% |
| AlphaCentric Advisors LLC | 110,000 | $1,624,700 | 0.92% |
| HighVista Strategies LLC | 133,000 | $1,964,410 | 0.91% |
| Affinity Asset Advisors, LLC | 200,000 | $2,954,000 | 0.83% |
| Rock Springs Capital Management LP | 1,813,758 | $26,789,206 | 0.72% |